These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 24094372)

  • 1. [18F-FDG-PET-CT in soft tissue sarcomas: when to image?].
    Rodríguez-Alfonso B; Mucientes Rasilla J; Mitjavila Casanovas M; Cardona Arboniés J; Cubedo R
    Rev Esp Med Nucl Imagen Mol; 2014; 33(1):43-9. PubMed ID: 24094372
    [No Abstract]   [Full Text] [Related]  

  • 2. Value of FDG PET/CT in Patient Management and Outcome of Skeletal and Soft Tissue Sarcomas.
    Sheikhbahaei S; Marcus C; Hafezi-Nejad N; Taghipour M; Subramaniam RM
    PET Clin; 2015 Jul; 10(3):375-93. PubMed ID: 26099673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FDG PET/MR in initial staging of sarcoma: Initial experience and comparison with conventional imaging.
    Platzek I; Beuthien-Baumann B; Schramm G; Maus J; Laniado M; Kotzerke J; van den Hoff J; Schuler M
    Clin Imaging; 2017; 42():126-132. PubMed ID: 27951459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical value of [18-F]] fluorodeoxyglucose positron emission tomography imaging in soft tissue sarcomas.
    Schwarzbach MH; Dimitrakopoulou-Strauss A; Willeke F; Hinz U; Strauss LG; Zhang YM; Mechtersheimer G; Attigah N; Lehnert T; Herfarth C
    Ann Surg; 2000 Mar; 231(3):380-6. PubMed ID: 10714631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional image in soft tissue sarcomas: An update of the indications of
    Rodríguez-Alfonso B; Simó-Perdigó M; Orcajo Rincón J
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2020; 39(4):233-243. PubMed ID: 32616457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic value of
    Kassem TW; Abdelaziz O; Emad-Eldin S
    Diagn Interv Imaging; 2017 Oct; 98(10):693-698. PubMed ID: 28734778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrated 18F-FDG PET/MRI compared to MRI alone for identification of local recurrences of soft tissue sarcomas: a comparison trial.
    Erfanian Y; Grueneisen J; Kirchner J; Wetter A; Podleska LE; Bauer S; Poeppel T; Forsting M; Herrmann K; Umutlu L
    Eur J Nucl Med Mol Imaging; 2017 Oct; 44(11):1823-1831. PubMed ID: 28567495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Necrosis on FDG PET/CT correlates with prognosis and mortality in sarcomas.
    Rakheja R; Makis W; Tulbah R; Skamene S; Holcroft C; Nahal A; Turcotte R; Hickeson M
    AJR Am J Roentgenol; 2013 Jul; 201(1):170-7. PubMed ID: 23789672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 18F-FDG PET-CT in soft tissue sarcomas: staging, restaging, and prognostic value?
    Gabriel M; Rubello D
    Nucl Med Commun; 2016 Jan; 37(1):3-8. PubMed ID: 26457597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of fluorodeoxyglucose positron emission tomography in the management of soft-tissue sarcomas.
    Lucas JD; O'Doherty MJ; Wong JC; Bingham JB; McKee PH; Fletcher CD; Smith MA
    J Bone Joint Surg Br; 1998 May; 80(3):441-7. PubMed ID: 9619933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meta-Analysis of the Diagnostic Accuracy of Primary Bone and Soft Tissue Sarcomas by 18F-FDG-PET.
    Younis MH; Abu-Hijleh HA; Aldahamsheh OO; Abualruz A; Thalib L
    Med Princ Pract; 2020; 29(5):465-472. PubMed ID: 31887730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. F-18 FDG-PET for detection of osseous metastatic disease and staging, restaging, and monitoring response to therapy of musculoskeletal tumors.
    Peterson JJ
    Semin Musculoskelet Radiol; 2007 Sep; 11(3):246-60. PubMed ID: 18260035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual-time point 18FDG-PET/CT imaging may be useful in assessing local recurrent disease in high grade bone and soft tissue sarcoma.
    Dancheva Z; Bochev P; Chaushev B; Yordanova T; Klisarova A
    Nucl Med Rev Cent East Eur; 2016; 19(1):22-7. PubMed ID: 26841376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nodular fasciitis mimicking soft tissue metastasis on 18F-FDG PET/CT during surveillance.
    Kim JY; Park J; Choi YY; Lee S; Paik SS
    Clin Nucl Med; 2015 Feb; 40(2):172-4. PubMed ID: 25140556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proximal-type epithelioid sarcoma of the scrotum: 18F-FDG PET/CT imaging.
    Nguyen VX; Nguyen BD
    Clin Nucl Med; 2013 Jan; 38(1):e45-7. PubMed ID: 23242066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole-body positron emission tomography with 18F-fluorodeoxyglucose is an effective method to detect extra-pelvic recurrence in uterine sarcomas.
    Sung PL; Chen YJ; Liu RS; Shieh HJ; Wang PH; Yen MS; Wen KC; Shen SH; Lai CR; Yuan CC
    Eur J Gynaecol Oncol; 2008; 29(3):246-51. PubMed ID: 18592788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sarcoma.
    Ceyssens S; Stroobants S
    Methods Mol Biol; 2011; 727():191-203. PubMed ID: 21331935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positron emission tomography of soft tissue sarcomas.
    Israel-Mardirosian N; Adler LP
    Curr Opin Oncol; 2003 Jul; 15(4):327-30. PubMed ID: 12874512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of several FDG PET parameters for prediction of soft tissue tumour grade at primary diagnosis and recurrence.
    Fendler WP; Chalkidis RP; Ilhan H; Knösel T; Herrmann K; Issels RD; Bartenstein P; Cyran CC; Lindner LH; Hacker M
    Eur Radiol; 2015 Aug; 25(8):2214-21. PubMed ID: 25693667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positron emission tomography/computed tomography with 18fluoro-deoxyglucose in the detection of local recurrence and distant metastases of pediatric sarcoma.
    Arush MW; Israel O; Postovsky S; Militianu D; Meller I; Zaidman I; Sapir AE; Bar-Shalom R
    Pediatr Blood Cancer; 2007 Dec; 49(7):901-5. PubMed ID: 17252575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.